Last reviewed · How we verify
concentrate of red blood cells
concentrate of red blood cells is a Biologic drug developed by Michał Stasiowski. It is currently in Phase 1 development. Also known as: RBC.
At a glance
| Generic name | concentrate of red blood cells |
|---|---|
| Also known as | RBC |
| Sponsor | Michał Stasiowski |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) (PHASE3)
- Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients (PHASE3)
- Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment. (NA)
- A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease (PHASE3)
- A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises (PHASE3)
- Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
- Erythrocyte Transfusion Based on the Measurement of Central Venous Oxygen Saturation in Postoperative Cardiac Surgery (NA)
- Perioperative Blood Transfusion and Increased One-year Mortality
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- concentrate of red blood cells CI brief — competitive landscape report
- concentrate of red blood cells updates RSS · CI watch RSS
- Michał Stasiowski portfolio CI
Frequently asked questions about concentrate of red blood cells
What is concentrate of red blood cells?
concentrate of red blood cells is a Biologic drug developed by Michał Stasiowski.
Who makes concentrate of red blood cells?
concentrate of red blood cells is developed by Michał Stasiowski (see full Michał Stasiowski pipeline at /company/micha-stasiowski).
Is concentrate of red blood cells also known as anything else?
concentrate of red blood cells is also known as RBC.
What development phase is concentrate of red blood cells in?
concentrate of red blood cells is in Phase 1.
Related
- Manufacturer: Michał Stasiowski — full pipeline
- Also known as: RBC
- Compare: concentrate of red blood cells vs similar drugs
- Pricing: concentrate of red blood cells cost, discount & access